QUALIFIKATIONEN

2018          „Fellow of the European Society of Cardiology“ (FESC)

2018          Qualifikation „kathetergestützte Aortenklappenimplantation“ (TAVI)

2015          Zusatzqualifikation „Interventionelle Kardiologie“ der deutschen Gesellschaft für Kardiologie (DGK)

2014          Facharzt für Innere Medizin und Kardiologie

2013          Dissertation, Universität Heidelberg

2008          „Full Medical Registration“, General Medical Council (GMC), London, UK

2006          Ärztliche Approbation, Bezirksregierung Köln, Deutschland

2005          Ärztliche Prüfung, Medizinische Fakultät, Universität zu Köln, Deutschland

AKADEMISCHER & KLINISCHER WERDEGANG

2017 - heute 

Oberarzt. Klinik für Kardiologie, Angiologie und Pneumologie (MED III), Universitätsklinikum Heidelberg. 

Direktor Univ. Prof. Dr. med. Hugo A. Katus / Direktor Univ. Prof. Dr. med. Norbert Frey.

2018 - 2020                      

Stellvertretender Chefarzt, Leiter des Herzkatheterlabors. Abteilung für Kardiologie/Angiologie, Krankenhaus Eberbach (Lehrkrankenhaus der Universität Heidelberg). 

Direktor Univ. Prof. Dr. med. Hugo A. Katus.

2018 - heute                          

Gründer und Leiter des Programms für komplexe Koronarinterventionen (CHIP & CTO), Herzkatheterlabore. Klinik für Kardiologie, Angiologie und Pneumologie (MED III), Universitätsklinikum Heidelberg.

2009 - heute

Klinik für Kardiologie, Angiologie und Pneumologie (MED III), Universitätsklinikum Heidelberg.

2006 - 2008

Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (MED I), Universitätsklinikum Aachen. 

Direktor Univ. Prof. Dr. med. Malte Kelm.

1999 - 2005                      

Studium der Humanmedizin, Medizinische Fakultät, Universität zu Köln.

VERÖFFENETLICHUNGEN

• Abu Sharar H, Wohlleben D, Vafaie M, Kristen AV, Volz HC, Bekeredjian R, Katus HA, Giannitsis E. Coronary Angiography-Related Myocardial Injury as Detected by High-Sensitivity Cardiac Troponin T Assay. EuroIntervention. 2016 Jun 20; 12(3):337-44.
• Abu Sharar H, Katus HA, Bekeredjian R. Bail-Out SYNERGY Stent Implantation in Complex Coronary Artery Lesions. J Am Coll Cardiol Intv. 2016; 9(4S):S16-S16. Abstract. doi.org/10.1016/j.jcin.2015.12.076.
• Abu Sharar H, Gomes B, Chorianopoulos E, Kaya Z, Gleissner CA, Katus CA, Bekeredijan R. Procedural advantages of a novel coronary stent design with ultra-thin struts and bioabsorbable abluminal polymer coating in an all-comers registry. Adv Interv Cardiol 2018; 14, 3(53): 240-46.
• Abu Sharar H, Helfert S, Vafaie M, Pleger ST, Chorianopoulos E, Bekeredjian R, Katus HA, Giannitsis E. Identification of Patients at Higher Risk for Myocardial Injury Following Elective Coronary Artery Intervention. Catheter Cardiovasc Interv. 2019 Oct 22.
• Abu Sharar H, Katus HA, Bekeredjian R. Pitfalls of bioresorbable vascular scaffold thrombosis - be sure to cover it all. Int J Cardiol. 2014 Dec 20; 177(3):1067-8.
• Reddy RK, Koeckerling D, Eichhorn C, Jamil Y, Ardissino M, Braun V, Abu Sharar H, Frey N, Howard JP, Ahmad Y. Early Invasive or Conservative Strategies for Older Patients with Acute Coronary Syndromes: A Meta-Analysis. JAMA Intern Med. Published online June 23, 2025. doi:10.1001/jamainternmed.2025.2058
• Vafaie M, Biener M, Mueller M, Abu Sharar H, Hartmann O, Hertel S, Katus HA, Giannitsis E. Addition of copeptin improves diagnostic performance of point-of-care testing (POCT) for cardiac troponin T in early rule-out of myocardial infarction - A pilot study. Int J Cardiol. 2015 Nov 1; 198:26-30.
• Kreusser MM, Pleger ST, Abu Sharar H, Geis NA, Bekeredjian R, Katus HA, Raake PW. Transient elevation of high-sensitive troponin T after Cardioband implantation. Herz. 2018 Sep 25.
• Geis N, Raake P, Kiriakou C, Mereles D, Frankenstein L, Abu Sharar H, Chorianopoulos E, Katus HA, Bekeredjian R, Pleger ST. Temporary oral anticoagulation after MitraClip - a strategy to lower the incidence of post-procedural stroke? Acta Cardiol. 2019 Jan 16:1-7.
• Pleger ST, Geis N, Kreusser M, Abu Sharar H, Sebening C, Szabo G, Katus HA, Raake PWJ. Percutaneous mitral valve repair in recurrent severe mitral valve regurgitation after mitral annuloplasty : MitraClip-in-the-ring as a complementary strategy. Herz. 2019 Nov 26
• Feistritzer HJ, Jobs A, Zeymer U, Schneider S, Lauten P, Ferenc M, Weferling M, Brinkmann R, Winkler S, Landmesser U, Trippel T, Stellbrink C, Wienbergen H, Fürnau G, Möllmann H, Linke A, Jung C, Lauten A, Achenbach S, Rassaf T, Schmitz T, Cremer S, Olivier C, Schächinger V, Sossalla S, Toischer K, Templin C, Sedding D, Clemmensen P, Tigges E, Meincke F, Abu Sharar H, Kulenthiran S, Schulze PC, Jacobshagen C, Frank D, Baldus S, Lehmann R, Spies C, Klein N, Eitel I, Zahn R, Schmeisser A, Gori T, Lurz P, Akin I, Chatzis G, Rizas K, Kessler T, Ademaj F, Elsässer A, Maier L, Öner A, Staudt A, Werner N, Geisler T, Keßler M, Ferrari MW, Seyfarth M, Nordbeck P, Ewen S, Bietau C, Haghikia A, Reinstadler SJ, Geppert A, Hösler N, Toth-Gayor G, Billmann B, Tschierschke R, Schmidt C, Fichtlscherer S, Thiele H; COMPLETE-NSTEMI Investigators. Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trial. Am Heart J. 2025 Sep;287:94-106. doi: 10.1016/j.ahj.2025.04.007. Epub 2025 Apr 8. PMID: 40209841
• Short-term and Long-term forecasting of clinical events in the Multivessel TALENT Trial with de novo three vessel coronary artery disease population. Accepted abstract TCT 2025
• Best PCI practice in Three Vessel Disease Combining SYNTAX Score, CTO expertise, angiography derived Physiology, Post-PCI Intravascular Imaging and One Month DAPT: The Multivessel TALENT  randomized  trial comparing Supraflex CruzTM and SYNERGYTM. Accepted Late breaking clinical trials - TCT 2025
• The Device Success Algorithm of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Prospectively Applied to Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in the International Multivessel TALENT Randomized Trial. Pruthvi C. Revaiah, Asahi Oshima, Adrian Wlodarczak, Helge Möllmann, Raul Moreno, Manel Sabate, Marc Silvestri, Jacek Legutko, Milosz Dziarmaga, Anirban Choudhury, Faisal Sharif, Simone Biscaglia, Joanna Wykrzykowska, Maciej Lesiak, Abhishek Kumar, Nicolas Meneveau, Ignacio Jesús Amat Santos, Janusz Kochman, Mariusz Tomaniak, Azfar Zaman, Michael Magro, Murugapathy Veerasamy, Peter O’Kane, Giuseppe Tarantini, Robert Jozwa, Thomas Schmitz, Stephan Achenbach, Andrew McNeice, Eric van Belle, Joan Antoni Gomez Hospital, Sen Devadathan, Stanislaw Bartus, Piotr Wacinski, Benoit Lattuca, Kenneth Morgan, Haitham Abu Sharar, Andrzej Ochala, Tanja Rudolph, James Cockburn, Robert Gil, Juan Sanchis Fores, Giovanni Esposito, Aishwarya Gurav, TsungYing Tsai, Kotaro Miyashita, Akihiro Tobe, Emma Harte, Gráinne Ní Bheoláin, Jibin Kachappilly Tomy, Yoshinobu Onuma, and Patrick Serruys. JACC. Journal of the American College of Cardiology. Volume 84, Number 18 Supplement 2024 Oct.